A novel EGFR inhibitor HNPMI regulates apoptosis and oncogenesis by modulating BCL2BAX and p53 in colon cancer

Jeyalakshmi KandhaveluKumar SubramanianVivash NaidooG SebastianelliP DoanS K ManiH YapislarE et alClement Penny2024-10-082024-10-08WOS0007-1188https://hdl.handle.net/10539/41438A novel EGFR inhibitor HNPMI regulates apoptosis and oncogenesis by modulating BCL2BAX and p53 in colon cancerJournal Article